Publications by authors named "Peter C Appelbaum"

Claim this Profile
A
Antistaphylococcal activity of oritavancin and its synergistic effect in combination with other antimicrobial agents.
Gengrong Lin, Glenn Pankuch, Peter C Appelbaum, Klaudia Kosowska-Shick

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2012 and beyond: potential for the start of a second pre-antibiotic era?
Peter C Appelbaum

J Antimicrob Chemother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.
Gengrong Lin, Glenn A Pankuch, Peter C Appelbaum, Klaudia Kosowska-Shick

Diagn Microbiol Infect Dis· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Rodrigo E Mendes, Athanassios Tsakris, Helio S Sader, Ronald N Jones, Donald Biek, Peter C Appelbaum

J Antimicrob Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Sandrine Lemaire, Francoise Van Bambeke, Denis Pierard, Peter C Appelbaum, Paul M Tulkens

Clin Infect Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.
Glenn A Pankuch, Gengrong Lin, Aya Kubo, Eliana S Armstrong, Peter C Appelbaum

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
Pamela McGhee, Catherine Clark, Kim Credito, Linda Beachel, Glenn A Pankuch, Peter C Appelbaum

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
Catherine Clark, Pamela McGhee, Peter C Appelbaum, Klaudia Kosowska-Shick

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.
Glenn A Pankuch, Gengrong Lin, Catherine Clark, Peter C Appelbaum

Antimicrob Agents Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.
Sandrine Lemaire, Klaudia Kosowska-Shick, Peter C Appelbaum, Y Glupczynski, Françoise Van Bambeke

J Antimicrob Chemother· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid detection of vancomycin-non-susceptible Staphylococcus aureus using the spiral gradient endpoint technique.
Vijaya C Doddangoudar, Margaret M O'Donoghue, Maureen V Boost, Dominic N C Tsang, Peter C Appelbaum

J Antimicrob Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiral gradient endpoint susceptibility testing: a fresh look at a neglected technique.
Rocky Pong, Maureen V Boost, Margaret M O'Donoghue, Peter C Appelbaum

J Antimicrob Chemother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
Klaudia Kosowska-Shick, Kathleen G Julian, Pamela L McGhee, Peter C Appelbaum, Cynthia J Whitener

Diagn Microbiol Infect Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant prevention concentrations of four carbapenems against gram-negative rods.
Kim Credito, Klaudia Kosowska-Shick, Peter C Appelbaum

Antimicrob Agents Chemother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Glenn A Pankuch, Harald Seifert, Peter C Appelbaum

Diagn Microbiol Infect Dis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.
Sandrine Lemaire, Klaudia Kosowska-Shick, Peter C Appelbaum, Gunther Verween, Paul M Tulkens

Antimicrob Agents Chemother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
Gengrong Lin, Lois M Ednie, Peter C Appelbaum

Antimicrob Agents Chemother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Gengrong Lin, Glenn A Pankuch, Lois M Ednie, Peter C Appelbaum

Antimicrob Agents Chemother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.
Kim Credito, Klaudia Kosowska-Shick, Pamela McGhee, Glenn A Pankuch, Peter C Appelbaum

Antimicrob Agents Chemother· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Pamela McGhee, Catherine Clark, Klaudia M Kosowska-Shick, Kensuke Nagai, Bonifacio Dewasse, Peter C Appelbaum

Antimicrob Agents Chemother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines.
Sandrine Lemaire, Françoise Van Bambeke, Peter C Appelbaum, Paul M Tulkens

J Antimicrob Chemother· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Klaudia Kosowska-Shick, Catherine Clark, Glenn A Pankuch, Pamela McGhee, Bonifacio Dewasse, Peter C Appelbaum

Antimicrob Agents Chemother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
Catherine Clark, Klaudia Kosowska-Shick, Pamela McGhee, Bonifacio Dewasse, Linda Beachel, Peter C Appelbaum

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative antipneumococcal activities of sulopenem and other drugs.
Klaudia Kosowska-Shick, Lois M Ednie, Pamela McGhee, Peter C Appelbaum

Antimicrob Agents Chemother· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
Klaudia Kosowska-Shick, Pamela McGhee, Peter C Appelbaum

Antimicrob Agents Chemother· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis